Alzheimer's patients and those who care for them now have hope when it comes to treatment in a way they have never had before. Earlier this month, the FDA gave approval to Leqembi, which has been shown to slow the progression of Alzheimer's by as much as 27 percent. While there is a lot of excitement around the research and advancements, some families impacted by the disease who have concerns.